PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
127.85%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
-4.11%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.11%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-9.81%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.92%
Share change of 1.92% while VALMT.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.92%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-133.84%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-273.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-32.13%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 3.33%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-34.81%
Negative 5Y CAGR while VALMT.HE stands at 3.33%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-4.61%
Negative 3Y CAGR while VALMT.HE stands at 3.33%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-209.24%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 160.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-165.31%
Negative 5Y OCF/share CAGR while VALMT.HE is at 160.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-159.11%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 160.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.17%
Net income/share CAGR above 1.5x VALMT.HE's 0.00% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-12.50%
Negative 5Y net income/share CAGR while VALMT.HE is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
250.00%
3Y net income/share CAGR above 1.5x VALMT.HE's 0.00%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-1.01%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
38.46%
Positive short-term equity growth while VALMT.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while VALMT.HE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
42.10%
Our AR growth while VALMT.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.75%
Inventory growth well above VALMT.HE's 5.31%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.51%
Positive asset growth while VALMT.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-5.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
5.85%
Debt growth far above VALMT.HE's 0.27%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.18%
We cut SG&A while VALMT.HE invests at 58.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.